drugset / Trial / NCT03452267
Insulin Signaling in Skeletal Muscle
RandomizedParallel-groupOpen-labelOther
Summary
The insulin sensitizing effects of metformin and pioglitazone in the skeletal muscle remain unknown. Our group aims to analyze molecular changes within the skeletal muscle of pre-diabetic patients through the use of a clinical trial in humans.
Timeline
- Start
- 2019-09-01
- Primary completion
- 2024-12
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | Oral |
| Subject | Pioglitazone | Small molecule | 45 mg | Oral |
Indications
No indication recorded.